Protective effect of Resveratrol against nephrotoxicity of nicotine in male rat: Antioxidant and histopathological approaches
DOI:
https://doi.org/10.56511/JIPBS.2016.v3.i04.pp125-132Abstract
Background and Objective: The deleterious health effects of cigarette smoking are remaining the most important convertible risk factor for improving overall mortality. In addition to being a risk factor for kidney disease, there is strong evidence that demonstrating a role for cigarette smoking in the progression of chronic kidney disease (CKD). Nicotine can freely cross the biological membranes of body organs. Resveratrol is a compound which is a member of plant compounds called polyphenols which possess a free radical scavenger. The study aimed to evaluate the influence of Resveratrol (Res) in rat with Nicotine (Nic) induced nephrotoxicity, by evaluating the biochemical and histopathological changes. Methodology: The experiment was carried out on four groups of male rats as follows; The first group served as a control group, 2nd group was treated with Nic (2.5 mg kg-1) dissolved in physiological saline, 3rd group was received Res (20 mg Kg-1), 4th group was treated with combination of Nic (2.5 mg Kg-1) and Res (20 mg Kg-1). Results: The results indicated that Nic increased Uric acid, Urea, Creatinine, lipid peroxidation, TOS level and decrease the antioxidant enzymes as well as decrease the thiol and G6PD levels. A serious congestion, correlated with kidney was observed in Nic treatment and the role of Res in improving all the oxidative damage and the histopathological changes in kidney. In the light of the present results, it is evident that Res was able to reduce the nephrotoxic effect of Nic in male rats.
Keywords:
Nicotine, Resveratrol, Kidney, Oxidative stress, HistopathologyDownloads
References
World Health Organization, 2013. WHO Report on the Global Tobacco Epidemic, 2013: Enforcing Bans on Tobacco Advertising, Promotion and Sponsorship.(in IRIS). World Health Organization, Geneva.
Messer K, Trinidad DR, Al-Delaimy WK, Pierce JP: Smoking cessation rates in the United States: a comparison of young adult and older smokers. Am. J. Public Health 2008; 98:317 – 322.
Benowitz N: Pharmacology of nicotine: addiction, smoking-induced disease, and therapeutics. Annu. Rev. Pharmacol. Toxicol 2009; 49:57 – 71.
Corrigall WA, Franklin KB, Coen KM, Clarke PB: Themesolimbic dopaminergic system is implicated in the reinforcing effects of nicotine. Psychopharmacology 1992; 107:285 – 289.
De Villiers SH, Lindblom N, Kalayanov G, Gordon S, Baraznenok I, Malmerfelt A, Marcus MM, M.Johansson A, Svensson TH: Nicotine hapten structure, antibody selectivity and effect relationships: results from a nicotine vaccine screening procedure. Vaccine 2010; 28:2161 – 2168.
Leonard SS, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, Shi X: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses, Biochem. Biophys. Res. Commun 2003; 309:1017 – 1026.
Uenobe F, Nakamura S, Miyazawa M: Antimutagenic effect of resveratrol against Trp-P-1, Mutat. Res 1997; 373:197 – 200.
Bertelli AA, Ferrara F, Diana G, Fulgenzi A, Corsi M, Ponti W, Ferrero ME, Bertelli A: Resveratrol, a natural stilbene in grapes and wine, enhances intraphagocytosis in human promonocytes: a co-factor in antiinflammatory and anticancer chemopreventive activity, Int. J. Tissue React 1999; 21:93 – 104.
Aggarwal BB, Bhardwaj A, Aggarwal RS, Seeram NP, Shishodia S, Takada Y: Role of resveratrol in prevention and therapy of cancer: preclinical and clinical studies, Anticancer Res 2004; 24:2783 – 2840.
Das S, Das DK: Resveratrol: a therapeutic promise for cardiovascular diseases, Recent Pat. Cardiovasc. Drug Discov 2007; 2:133 – 138.
Brisdelli F, D'Andrea G, Bozzi A: Resveratrol: a natural polyphenol with multiple chemopreventive properties. Curr Drug Metab 2009; 10:530 – 46.
Leiro J, Alvarez E, Arranz JA, Laguna R, Uriarte E, Orallo F: Effects of cis-resveratrol on inflammatory murine macrophages: antioxidant activity and down-regulation of inflammatory genes. J Leukoc Biol 2004; 75:1156 – 65.
De la Lastra CA, Villegas I:Resveratrol as an anti-inflammatory and antiaging agent: mechanisms and clinical implications. Mol Nutr Food Res 2005; 49:405 – 30.
Kalpana C, Menon VP: Protective effect of curcumin on circulatory lipid peroxidation and antioxidant status during nicotine-induced toxicity. Toxicol Mech Methods 2004; 14:339 – 43.
Oktem G, Uysal A, Oral O, Sezer ED, Olukman M, Erol A: Resveratrol attenuatesdoxorubicin-induced cellular damage by modulating nitric oxide and apoptosis. Exp Toxicol Pathol 2012; 64:471 – 9.
Boussarie D: Hématologie des rongeurs et lagomorphes de compagnieBull. Acad. Vét. De France 1999;72: 209-216.
Erel O: A novel automated direct measurement method for total antioxidant capacity using a new generation, more stable ABTS radical cation. Clin. Biochem 2004; 37: 277 – 285.
Erel O: A new automated colorimetric method for measuring total oxidant status. Clin. Biochem 2005; 38:1103 – 1111.
Esterbauer H, Cheeseman KH: Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol 1990; 186: 407 – 421.
Marklund S, Marklund G: Involvement of the superoxide anion radical in the autoxidation of pyrogallol and a convenient assay for superoxide dismutase". Europ. J. Biochem 1974; 47: 469 – 474.
Aebi DJ: Glucose-6-phosphate dehydrogenase. In: Bergmeyer HU, editor. Methods of enzymatic analysis. 2nd ed. Weinheim: VCH Verlagsgesellschaft mbH 1986; 190 – 6.
Hafeman D, Sunde G and Hoekstra WG: Effect of dietary selenium on erythrocyte and liver glutathione peroxidase in the rat. J. Nulr 1974; 104:580-587.
Prieto P, Pineda M, Aguilar M: Spectrophotometric quantitation of antioxidant capacity through the formation of a Phosphomolybdenum complex specific application to the determination of vitamin E. Anal. Biochem 1999; 269:337 – 341.
MY, Hamed RR: colorimetric method for the determination of guanine and xanthine and its application to the assay of xanthine oxidase, Microchemical Journal 1980; 25(3 ): 323-329.
Hu ML: Measurement of protein thiol groups and glutathione in plasma. Methods Enzymol 1994; 233:380 – 5.
Gabe M: Techniques histologiques [Histological Techniques]. Paris: Masson Publisher 1968.
Grassi G, Seravalle G, Calhoun DA, Bolla GB, Giannattasio C, Marabini M: Mechanisms responsible for sympathetic activation by cigarette smoking in humans. Circulation 1994; 90:248 – 53.
Halimi JM, Philippon C, Mimran A: Contrasting renal effects of nicotine in smokers and non-smokers. Nephrol Dial Transplant 1998; 13:940 – 4.
Orth SR: Effects of smoking on systemic and intrarenal hemodynamics: influence on renal function. J Am Soc Nephrol 2004; 15(Suppl 1):S58 – 63.
Orth SR, Stockmann A, Conradt C, Ritz E, Ferro M, Kreusser W:Smoking as a risk factor for end-stage renal failure in men with primary renal disease. Kidney Int 1998; 54:926 – 31.
Yildiz D: Nicotine, its metabolism and an overview of its biological effects. Toxicon 2004; 43:619 – 32.
Snyder MJ, Hsu E, Feyereisen R: Induction of cytochrome P-450 activities by nicotine in the tobacco hornworm, manduca sexta. J Chem Ecol 1993; 19: 2903 – 10.
Carpagnano GE, Kharitonov SA, Foschino-Barbaro MP, Resta O, Gramiccioni E, J.Barnes P: Increased inflammatory markers in the exhaled breath condensate of cigarette smokers. Eur Respir J 2003; 21(4):589 – 93.
Hackett NR, Heguy A, Harvey BG, Kalpan R: Variability of antioxidant related gene expression in the airway epithelium of cigarette smokers. Am J Respir Cell Mol Bio 2003; 29(3):733 – 44.
Anthony JC, Echeagaray-Wagner F: Epidemiologic analysis of alcohol and tobacco use. Alcohol Res Health 2000; 24:201 – 8.
Falk DE, Yi HY, Hiller-Sturmho¨ fel S: An epidemiologic analysis of cooccurring alcohol and tobacco use and disorders: findings from the National Epidemiologic Survey on alcohol and related conditions. Alcohol Res Health 2006; 29: 162 – 71.
Mamdouh Y, Kamel R, Ragaa H: A colorimetric method for the determination of guanine and xanthine and its application to the assay of xanthine oxidase, Microchemical Journal 1980; 25(3 ):323-329.
Sekhon H, Proskocil BJ, Clark JA: Spindel ER. Prenatal nicotine exposure increases connective tissue expression in fetal monkey pulmonary vessels. Eur Respir J 2004; 23:906 – 15.
Schievelbein H, Balfour DJK: Nicotine and the tobacco smoking habit. Oxford: Pergamon Press 1984:1 – 15.
Arichi H, Kimura Y, Okuda H, Baba K, Kozawa M, Arichi S,: Effects of stilbene components of the roots of Polygonum cuspidatum Sieb et Zucc on lipid metabolism. Chem. Pharm. Bull 1982; 30: 1776 – 1770.
Wang Y, Catana F, Yang R, Roderick R, Van Breemen RB:Analysis of resveratrol in grape products, cranberry juice and wine using liquid chromatography - mass spectrometry. J. Agric. Food Chem 2002; 50:431 – 435.
Silan C, Uzun O, Comunog˘lu NU, Golcen S, Bedirhan S, Cengiz M: Gentamicin-induced nephrotoxicity in rats ameliorated and healing effects of resveratrol. Biol. Pharm. Bull 2007; 30:79 – 83.
Leonard S, Xia C, Jiang BH, Stinefelt B, Klandorf H, Harris GK, Shi X: Resveratrol scavenges reactive oxygen species and effects radical-induced cellular responses. Biochem. Biophys. Res. Commun 2003; 309:1017 – 1026.
Mosbah R, Yousef MI, Mantovani A: Nicotine-induced reproductive toxicity, oxidative damage, histological changes and haematotoxicity in male rats: The protective effects of green tea extract . Experimental and Toxicologic Pathology 2015; 67(3): 253-259.
El-Shenawy NS, AL-Harbi MS, Hamza RZ: Effect of vitamin E and selenium separately and in combination on biochemical, immunological and histological changes induced by sodium azide in male mice. Experimental and Toxicologic Pathology 2014; 67: 65 – 76.
Hamza RZ, Ismail HAA, Khaled HE, El-Shenawy NS: Antioxidant effect of Lcysteine on sodium-valproate-induced oxidative stress in rat liver: biochemical and ultrastructural approaches. Toxicological and Environmental Chemistry 2015: 97(8): 1041-1056.
Paula ME, Mathangi DC, Namasivayam A: Free radical changes in methanol toxicity. Indian Journal of Physiology and Pharmacology 2003; 47:207-211.
Salahshoor M, Mohamadian S, Kakabaraei S, Roshankhah S, Jalili C: Curcumin improves liver damage in male mice exposed to nicotine. Journal of Traditional and Complementary Medicine 2016: 6(2): 176-183.
Zhou X, Sheng Y, Yang R, Kong X: Nicotine promotes cardiomyocyte apoptosis via oxidative stress and altered apoptosis-related gene expression,Cardiology 2010;115 : 243 – 250.
Sener G, Sehirli O, Ipci Y, Cetinel S, Cikler E: Protective effects of taurine against nicotine - in duced oxidative damage of rat urinary bladder and kidney. Pharmacology 2005; 74: 37 – 44.
Claude S, Gwen T, Geurt S, Carole K, Nike C, Fabrice M, Patrizia L, Bilo D, Luc B, Michel G, Sandrine F, Alain L: Nicotine Protects Kidney from Renal Ischemia/Reperfusion Injury through the Choliner gic Anti - Inflammatory Pathway. PLoS ONE 2007; 2(5): e469. doi:10.1371/journal.pone.0000469 .
Khadija M, Al - Khawaja MA, Nahla AH: The effect of nicotine on the liver and kidney of prepubertal Sprague Dawley rats. The FASEB Journal 2008; 22:1123.8.
Ghada S, Mahmoud SAA: Protective Effects of Vitamin C against Nicotine - Induced Oxidative Damage of Rat Liver and Kidney. IOSR Journal of Environmental Science, Toxicol ogy and Food Technology 2014; 8(12): 2319 - 2399 Ver. IV :50 - 63.
Published
How to Cite
Issue
Section
Copyright (c) 2016 Hayat A. A. Ismail
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.
Journal of Innovations in Pharmaceutical and Biological Sciences is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License. Based on a work at